These are best guesses from the biopharmacatalyst site. They mean nothing. I'm not trying to be negative, I'm just trying to let you all know I've been down this road before. If the outcome occurs then, it is merely coincidence.
Some public figures can almost seem like dear friends, I completely relate to and empathize with your loss. We shall overcome cancer someday.
The responses will continue to improve in most patients. 6 weeks or so from May 27 should be revealing.
You are talking about the nwbio site, correct?
Prostate does seem to have a higher profile once again.
He's hoping the space will be empty , and he will try to make it part of his recent knock knock joke series….knock knock, who's there? No one…evil laugh.
I found an interesting little calculator online. Anyway 500 people sitting and standing (mixed) can fill up 4000 square feet.
Approximately half or more of the 36 enrollees were still in early treatment 1-3 injections at the time the PR was released. This is what one might designate a "fluid situation" as their group results are too early to be determined. In this type of situation, might I suggest, if you want your company (NWBO) to have the fairest chance for a successful and accurate reading of the first phase, it is worth waiting 2 plus weeks from the PR until ASCO to see the results in the entire pool.
Meanwhile, the case studies are very helpful, inspiring, educational and interesting.
If the group results were released right now it might show a 50% or 100% response. In either case this may create an unnecessary negative response once we learn the final results at ASCO.
Imagine the real result is 80%. Then the previous 50% PR will have unnecessarily put some analysts off prematurely. On the other hand a previous 100% PR would have set expectations excessively high, and even an 80% response rate at ASCO might be a let down -- and panned by critics and extrapolated for further panning.
I hope this helps.
Maybe…but I think the odds of a PR simply hitting upon a term, which is otherwise used in science to classify tumors, is unlikely. I also think it is not very likely NWBO knew of the scientific meaning but decided to play with it in a PR to get more bang for their buck.
I would not be surprised if there was 95% tumor cell death but only partial collapse.
When you read the Triozzi study, the description of the dying tumor (previously a solid tumor), once taken from the body, was that it basically oozed clear liquid. This would be near my physical expectation with almost complete cell death but not quite complete structural collapse. Very interesting.
Burnaka, if you combine that with shrinkage in another tumor that was not injected, said patient subset probably accounted for only .001% of those diagnosed during eight years in that unselected hospital.
NWBO PR 5/15/2014
At that time, this patient's MRI scan showed EXTENSIVE NECROSIS AND PARTIAL COLLAPSE of the injected large tumor mass, and a CT scan showed some early indication of shrinkage of one of the non-injected metastasized tumors.
I do not normally take the "priority" side of shareholders in companies like NWBO, but let me suggest modifying your statement. Her priority is to reach approval for vaccine(s) in the shortest time possible while avoiding unnecessarily diluting share price, all the while preparing for an effective marketing, manufacturing and distribution ramp on a global basis. These are all interconnected. PPS should not fall precipitously on a chronic basis due to over-promising. Thus far, over the past 5 years, I believe Ms. Powers has done her job well, and the few times she overstated expectations, I don't believe it was intentional or negligent -- instead I think that circumstances slightly beyond her control extended timelines. I disagree with another poster's suggestion that she avoids giving too much information to keep the price per share low to attract investors. That poster might listen to her interviews on the floor of the stock exchange regarding her expectations for (then) future price share action.
Long Investor: "E does appear to equal MC Squarred."
Basher: "Dude, you can't even spell squared." LMFAOVUYGVOUY
Long: "You know what I mean."
Basher: "You mean to get an a.. whipping from your english teacher." ROTFLVUVUIVV
Long: "Anyway, I think I'll call my theory "relativity."
Basher: "Maybe like "relatives" making babies, you must be inbred." YGGOGGYG
Long: "Are you familiar with glistening oyster irritations projected to beings without a requisite background understanding?"
Basher: "RU on crack?" H(H(HGH(HHP(HU(RDFDFOIHPIJ
Long: "Not really, it's more like a beam of luminescence unlocking yet another nested riddle."
Basher: "You seriously need to think about your kid's college fund before investing in this pig-pen." &*&&)^^%%5976870787
RedHot, Thanks for responding to my spelling fiasco. I agree
Yes, I should not talk and type. I meant "whimper." Newman! Auto-Spell check!
Just an observation -- not a compliment.